Dermatol. praxi. 2020;14(2):105-108

News in extemporaneous compounding in dermatology

PharmDr. Jan Hašek
Lékárna Slovanka, Česká Lípa

The article provides a pharmacist's insight into the options of external treatment of skin infections using extemporaneous preparations. Selected formulations from the groups of antiseptic, antibiotic, and antifungal drugs are presented that have emerged in the recent years or that are only being introduced into the practice. Therefore, emphasis is placed on the correct concentration of active substances and their compatibility with other compounds and vehicles for the preparation to be stable and have the desired efficacy.

Keywords: compounding, antimicrobial treatment, wound treatment, acne vulgaris.

Published: June 18, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hašek J. News in extemporaneous compounding in dermatology. Dermatol. praxi. 2020;14(2):105-108.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Doporučené doby použitelnosti léčivých přípravků připravovaných v lékárně a požadavky na jakost čištěné vody [online]. [cit. 9.3.2020]. Dostupné z: http://www.sukl.cz/lekarny/lek-5-verze-9,
    2. Altmeyer P. Therapielexikon Dermatologie und Allergologie. 2. vyd. Berlin, Heidelberg: Springer-Verlag, 2005: 1032. Go to original source...
    3. Deutschen Arzneimittel-Codex (DAC)/Neues Rezeptur-Formularium (NRF). Stuttgart: Govi-Verlag Eschborn, 2015
    4. Höger P. Kinderdermatologie: Diff erenzialdiagnostik und Therapie bei Kindern und Jugendlichen, Verlag für Medizin und Naturwissenschaften, 2007.
    5. Garbe C, Reimann H. Dermatologische Rezepturen. 2 vyd. Stuttgard: Gregor Thieme Verlag, 2005: 320. Go to original source...
    6. Deutscher arzneimittel-codex. Neues rezeptur-formularium [online]. [cit. 20.1.2020]. Dostupné z: https://dacnrf.pharmazeutische-zeitung.de
    7. Zolliner TM. Atopische Dermatitis: mit 51 Tabellen, Berlin-Wien: Blackwell Wissenschafts-Verlag, 2002: 237.
    8. Sklenář Z. Magistraliter receptura v dermatologii. 1. vyd. Praha: Galén, 2009: 441.
    9. Hašek J. Nové léčivé látky v magistraliter receptuře XV - polihexanid. Prakt. Lékáren. 2017; 13(2): 71-74. Go to original source...
    10. Hašek. J. Nové léčivé látky v magistraliter receptuře XVIII - gentamicin-sulfát. Prakt. Lékáren. 2012; 8(3): 130-133. Go to original source...
    11. Wetenschappelijk Instituut Nederlandse Apothekers (WINAp). Formularium der Nederlandse Apothekers, 5. vyd. Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie Formularium der Nederlandse Apothekers, 5. vyd., Den Haag. 2013.
    12. Gloor M, Thoma K, Fluhr J. Dermatologische Externatherapie. Berlin, Heidelberg: Springer-Verlag, 2000: 469. Go to original source...
    13. Hašek J. Basiscreme DAC - nový krémový základ pro magistraliter přípravu II. Prakt. Lékáren. 2014; 10(6): 221-225.
    14. Hašek J. Nové léčivé látky v magistraliter receptuře XIV - mikonazol a mikonazol-nitrát. Prakt. lékáren. 2013; 9(4-5): 192-195.

    Return to the content


    Dermatology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.